Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
5 clinical trials · Condition
◉ Watch Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers (NCT05296005) | Ohio State University Comprehensive Cancer Center | 2025-12-31 |
| Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer (NCT04929392) | City of Hope Medical Center | 2022-01-25 |
| Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery (NCT04391049) | NRG Oncology | 2021-12-02 |
| Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma (NCT03784326) | M.D. Anderson Cancer Center | 2019-02-19 |
| Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer (NCT03776487) | M.D. Anderson Cancer Center | 2019-01-07 |
Track Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.